Scarica l'app Stockscreener
1.70
3.95%
-0.07
Dopo l'orario di chiusura:
1.71
0.01
+0.59%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché HUMA Giù?
Forum
Previsione
Precedente Chiudi:
$1.77
Aprire:
$1.77
Volume 24 ore:
4.31M
Relative Volume:
0.82
Capitalizzazione di mercato:
$270.02M
Reddito:
-
Utile/perdita netta:
$-110.78M
Rapporto P/E:
-1.5888
EPS:
-1.07
Flusso di cassa netto:
$-75.59M
1 W Prestazione:
+3.66%
1M Prestazione:
+8.28%
6M Prestazione:
+9.68%
1 anno Prestazione:
-70.74%
Intervallo 1D:
$1.67
$1.79
Intervallo di 1 settimana:
$1.55
$1.82
Portata 52W:
$1.15
$6.77
Humacyte Inc Stock (HUMA) Company Profile
Nome
Humacyte Inc
Settore
Industria
Telefono
919-313-9633
Indirizzo
2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM
Confronta HUMA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HUMA
Humacyte Inc
|
1.70 | 335.22M | 0 | -110.78M | -75.59M | -1.07 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Humacyte Inc Stock (HUMA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-27 | Iniziato | Barclays | Overweight |
| 2025-05-14 | Ripresa | H.C. Wainwright | Buy |
| 2024-12-20 | Reiterato | H.C. Wainwright | Buy |
| 2023-12-11 | Iniziato | H.C. Wainwright | Buy |
| 2023-08-14 | Aggiornamento | Piper Sandler | Underweight → Neutral |
| 2023-06-22 | Iniziato | Cantor Fitzgerald | Overweight |
| 2022-05-16 | Downgrade | Piper Sandler | Overweight → Underweight |
| 2021-10-29 | Iniziato | Cowen | Outperform |
| 2021-09-24 | Iniziato | Oppenheimer | Outperform |
| 2021-09-22 | Iniziato | BTIG Research | Buy |
| 2021-09-16 | Iniziato | Piper Sandler | Overweight |
Mostra tutto
Humacyte Inc Borsa (HUMA) Ultime notizie
Volume spikes in Humacyte Inc. Equity Warrant stock – what they mean2025 Price Momentum & Low Risk Entry Point Guides - newser.com
Humacyte (HUMA): Valuation in Focus After Promising Ukraine Trauma Results - Yahoo Finance
Is Humacyte Inc. stock trading near support levelsWeekly Trade Report & Weekly Sector Rotation Insights - newser.com
Humacyte Secures $60 Million in Oversubscribed Stock Offering to Advance Bioengineered Tissue Platform - citybuzz
Market reaction to Humacyte Inc.’s recent newsMarket Activity Report & AI Forecast for Swing Trade Picks - newser.com
Should I hold or sell Humacyte Inc. Equity Warrant stock in 20252025 Volatility Report & Low Drawdown Momentum Trade Ideas - newser.com
Live market analysis of Humacyte Inc. Equity Warrant2025 Dividend Review & Community Supported Trade Ideas - newser.com
Is Humacyte Inc. Equity Warrant forming a bottoming baseWeekly Trade Analysis & Daily Oversold Stock Bounce Ideas - newser.com
Understanding Humacyte Inc. Equity Warrant’s price movementBear Alert & Growth Focused Investment Plans - newser.com
Humacyte, Inc. (HUMA) Advances While Market Declines: Some Information for Investors - sharewise.com
D. Boral Capital Acted as Exclusive Placement Agent to Humacyte (Nasdaq: HUMA) in Connection with its $60,000,000 Registered Direct Offering - ACCESS Newswire
Applying sector rotation models to Humacyte Inc. Equity Warrant2025 Price Action Summary & Smart Investment Allocation Tips - newser.com
Applying chart zones and confluence areas to Humacyte Inc.July 2025 Movers & High Yield Equity Trading Tips - newser.com
Using fundamentals and technicals on Humacyte Inc. Equity WarrantEarnings Recap Summary & Risk Managed Investment Entry Signals - newser.com
Relative strength of Humacyte Inc. in sector analysisMarket Movers & Long-Term Growth Plans - newser.com
Building trade automation scripts for Humacyte Inc.Trade Entry Report & High Accuracy Trade Alerts - newser.com
Will Humacyte Inc. stock gain from government policiesJobs Report & Verified Short-Term Plans - newser.com
Can a trend reversal in Humacyte Inc. Equity Warrant lead to recoveryTrade Entry Summary & Entry Point Strategy Guides - newser.com
Humacyte (HUMA) Is Down 25.7% After Reporting Strong Symvess Trauma Results and Completing $60M Equity Raise - Yahoo Finance
Humacyte shares sink as it announces pricing of $60M direct offering - MSN
Advanced analytics toolkit walkthrough for Humacyte Inc.Take Profit & Long-Term Capital Growth Strategies - newser.com
Top chart patterns to watch in Humacyte Inc.Earnings Overview Summary & AI Powered Market Entry Ideas - newser.com
Real time social sentiment graph for Humacyte Inc.Weekly Stock Analysis & Capital Efficiency Focused Ideas - newser.com
Published on: 2025-10-10 04:58:04 - newser.com
Humacyte, Inc. (HUMA) Stock Analysis: Significant 413.94% Potential Upside Ignites Investor Interest - DirectorsTalk Interviews
Is Humacyte Inc. stock poised for growthWeekly Trade Report & Safe Capital Growth Plans - newser.com
Humacyte Announces $60M Stock and Warrants Offering - MSN
Published on: 2025-10-09 06:28:01 - newser.com
Is Humacyte Inc. Equity Warrant stock positioned for digital transformation2025 Retail Activity & Real-Time Volume Triggers - newser.com
Weiss Ratings Reiterates Sell (E+) Rating for Humacyte (NASDAQ:HUMA) - MarketBeat
Humacyte, Inc.Common Stock (NQ: - FinancialContent
Combat Trauma Study Results Might Change The Case For Investing In Humacyte (HUMA) - simplywall.st
What analysts say about Humacyte Inc stockRisk Mitigation Techniques & Fast Growing Investment Plans - earlytimes.in
Humacyte, Inc. (HUMA) Declines More Than Market: Some Information for Investors - Yahoo Finance
Investors Buy High Volume of Call Options on Humacyte (NASDAQ:HUMA) - MarketBeat
Humacyte: Shares Tank On Fundraising NewsWhat You Need To Know (NASDAQ:HUMA) - Seeking Alpha
Humacyte Gains 43%, Insider Trades Reap Benefit - Yahoo Finance
Humacyte Inc Azioni (HUMA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Humacyte Inc Azioni (HUMA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Dougan Brady W | Director |
Aug 18 '25 |
Sale |
1.83 |
549,360 |
1,005,329 |
1,691,685 |
| Dougan Brady W | Director |
Aug 20 '25 |
Sale |
1.58 |
591,685 |
934,862 |
0 |
| Niklason Laura E | President, CEO and Director |
Aug 19 '25 |
Sale |
1.63 |
1,100,000 |
1,793,000 |
591,685 |
| Niklason Laura E | President, CEO and Director |
Aug 18 '25 |
Sale |
1.83 |
549,360 |
1,005,329 |
1,691,685 |
| Niklason Laura E | President, CEO and Director |
Aug 20 '25 |
Sale |
1.58 |
591,685 |
934,862 |
0 |
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):